Degenerative Disc Disease clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

    open to eligible people ages 18 years and up

    The primary purpose of this study is to evaluate the efficacy of rexlemestrocel-L+HA compared to control in reducing low back pain at 12 months post-treatment and safety of a single injection of rexlemestrocel-L+HA injected into a lumbar intervertebral disc compared to control through 12 months post-treatment.

    San Francisco 5391959, California 5332921 and other locations

Last updated: